SYRE · Spyre Therapeutics, Inc.
$97.68
-2.28 (-2.28%)
At close · Jul 29
Going-concern doubt
— flagged May 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital to continue to fund our operations in the future. If we are unable to raise additional capital when needed, we will not be able to continue as a going concern.”View the 10-Q filed May 5, 2026
Market Cap
$8.68B
Shares
86.84M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-08 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-04-13 | Spyre Therapeutics SPY001 Part A Induction Results | Event |
Source: https://ir.spyre.com/
Key facts
CIK
1636282
CUSIP
00773J202
13F (30d)
22 filings
22 filers
Visit website
Investor relations